Skip to main content
OpenTrials
Completed

NCT Number: NCT01310972

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colon Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site

Age range

14 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kfsh & Rc

Riyadh, Saudi Arabia

About this study

It's a study of adjuvant colon carcinoma using ELOXatin/5-FU based chemotherapeutic regimen called ACCELOX as a definitive curative therapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Adjuvant Colon Cancer

Exclusion criteria

  • Patients with diagnosis other than Colon Cancer.

Treatment and study plan

Registry

Other

Registry

Primary outcomes

  1. OS, PFS, DFS

    Time frame: For the duration of the experiment

Sponsors and collaborators

Lead sponsor

King Faisal Specialist Hospital & Research Center

Other

Registry information

Official study title

Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Mar 9, 2011
Registry last updated
Aug 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.